Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The strategy of designing or using antibacterial agents that act on more than one molecular target within bacterial cells. This approach is increasingly important in combating antibiotic resistance, as drugs with multiple targets are less likely to be rendered ineffective by single-point mutations or resistance mechanisms. Targets include cell wall synthesis, protein synthesis, DNA replication, and membrane integrity. Multitargeting can be achieved through single molecules or combination therapies.
Inhibition of distinct enzymes from separate metabolic pathways; disruption of structural components; interference with genetic material; induction of multiple stress responses.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple Bacterial Targets (N/A).